Jocelyn M Ashford

Jocelyn M Ashford currently serves as a Member of the Board of Advisors at ScienceMedia, Inc., and the Head of US Corporate Affairs for Cardiovascular Renal Metabolism (CVRM) at AstraZeneca. Ashford also holds prominent roles as a Board Member of the Vasculitis Foundation and the Founder of Rare Advocate. Previously, Ashford was Vice President of Patient Advocacy at BridgeBio, where leadership involved connecting patients with the company and developing global advocacy strategies. With experience in various capacities at Eidos Therapeutics, Genentech, and AbbVie, Ashford has consistently focused on understanding patient needs and enhancing their experiences throughout the drug development process. Ashford holds a Master’s degree in Management from Northwestern University and has dedicated over a decade to advancing advocacy for rare diseases and their respective patient communities.